Device implantation: Implantation of single chamber, dual chambers or triple chambers PM/ICD
Study summary
The study is a prospective registry. Consecutive patients with indications of implant / replacement or upgrade of pacemaker (PM), implantable cardioverter defibrillator (ICD), Implanted loop recorder (ILR) will be enrolled.
The primary objective of the study is to describe the clinical events during a long-term follow-up of non-selected population of patients implanted with an PM, ICD or ILR.
Eligibility
Sex
ALL
Min age
14 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* All consecutive patients underwent PM/ICD/ILR implantation
* Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
* Patient must be able to attend all required follow-up visits at the study center for at least 12 months
Exclusion Criteria:
* No informed consent
* Patient is participating in another clinical study that may have an impact on the study endpoint
Exclusion Criteria:
* No informed consent
Primary outcome measure(s)
CIEDs Infection — through study completion, an average of 1 year The number of patecipants with infections following implantation of cardiac implantable electronic devices
Appropriate ICD Therapies Antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmia — through study completion, an average of 1 year The number of partecipants with a least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmias.
Inappropriate ICD Therapies — through study completion, an average of 1 year The number of partecipants with at least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected sopraventricular arrhythmias.
Trial sites (1)
Facility
City
Region
Status
Vincenzo Russo
Naples
Napoli
Recruiting
More University of Campania Luigi Vanvitelli trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.